Cover Image
市场调查报告书

神经刺激设备的全球市场的未来预测

GLOBAL NEUROSTIMULATION DEVICE MARKET FORECAST 2017-2025

出版商 Inkwood Research 商品编码 530650
出版日期 内容信息 英文 162 Pages
商品交期: 最快1-2个工作天内
价格
Back to Top
神经刺激设备的全球市场的未来预测 GLOBAL NEUROSTIMULATION DEVICE MARKET FORECAST 2017-2025
出版日期: 2017年07月19日 内容信息: 英文 162 Pages
简介

本报告提供全球神经刺激设备市场未来展望相关分析,市场基本结构、背景结构,及主要促进、阻碍因素,及市场整体及各产品、各用途、各地区的市场趋势预测 (今后9年份),目前市场向心力的水准和企业间竞争趋势,主要企业简介等调查。

第1章 分析范围

第2章 分析方法

第3章 摘要整理

第4章 市场决策要素

  • 市场的推动要素
  • 市场的阻碍要素
  • 市场机会
  • 市场课题

第5章 市场区隔

  • 各设备的市场区隔 (今后9年份)
    • 脊髓刺激设备 (SCS)
    • 深层脑部刺激器 (DBS)
    • 荐骨神经刺激器 (SNS)
    • 迷走神经刺激设备 (VNS)
    • 其他
  • 各用途的市场区隔 (今后9年份)
    • 疼痛管理
    • 癫痫
    • 原发性颤抖症
    • 尿失禁、便失禁
    • 忧郁症
    • 肌张力不全症
    • 胃不全麻痹
    • 帕金森氏症

第6章 主要指标

  • 波特的五力分析
  • 估计分析
    • 精神疾病的患病人数的增加
    • 全球各国的医疗费的扩大
    • 老年人口的增加
  • 价值链分析
    • 医药品相关:厂商、经销商、零售商店、终端用户
    • 医疗设备相关:厂商、经销商、终端用户
  • 市场机会矩阵
  • 供应商环境

第7章 地区分析

  • 北美 (美国、加拿大)
  • 欧洲 (英国、法国、德国、西班牙等)
  • 亚太地区 (印度、中国、日本、澳洲等)
  • 其他的国家 (RoW)

第8章 企业简介

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: 6409

KEY FINDINGS

The global neurostimulation device market which was worth $1902 million in 2016 is anticipated to grow at a CAGR of 8.67% during the forecast period of 2017-2025. Its net worth is estimated to rise up to $4004 million by the end of 2025. The fact that these devices aid in the therapeutic activation for many neurological diseases is majorly driving the market. Other factors include the high occurrence of diseases, second-line of treatment, increased elderly populace and the various developments in technology.

MARKET INSIGHTS

The global neurostimulation device market can be segmented on the basis of the type of system and by the application type. The different type of systems can be classified as Global DBS system market, Global SCS system market, Global SNS system market, Global VNS system market and Others. The application of the neurostimulation devices can be seen in Depression market, Pain management market, Essential tremor market, Epilepsy market, Urinary and fecal incontinence market, Dystonia market, Gastroparesis market and in Parkinson's disease market. Albeit such wide range of applications, safety concerns remains to be one of the major market challenges. Patients might be at a risk of contracting infections at the time of implantation or may face issues if they are in contact with or near to electromagnetic radiation and electrical and gas-powered appliances. Also, the malfunction of the implanted device might go unnoticed by the patient leading to higher risks.

REGIONAL INSIGHTS

Geographically, the market can be divided into four major regions, which includes:

North America - U.S. & Canada

Asia-Pacific - China, India, Japan, Australia, Rest of APAC

Europe - UK, France, Germany, Spain, and Rest of Europe

Rest of World

The Asia-Pacific market is predicted to show the fastest growth over the forecast period. Factors like a large patient base and the rising investments in healthcare sectors in countries like China and Japan are proving conducive to the market growth in this region. At present, however, the North America region is leading the market scene. The United States is a major revenue contributor to the global neurostimulation device market. The North American region is expected to continue this dominance and hold the highest share by 2025 in the global market. The market is wildly attracting investors from all over the globe because of profitable aspects like advances in technology and the US government's increased focus on improving patient safety and procedure efficiency by using neurostimulation devices.

COMPETITIVE INSIGHTS

St. Jude Medical is a global medical device manufacturer that develops medical technology, products, and services for the treatment of neurological, chronic pain, and cardiac patients. Another company, Boston Scientific caters to high-quality medical devices used in the treatment of a large number of medical conditions. Medtronic Inc. manufactures and sells device-centered medicinal treatments globally along with assembling intra-operative imaging systems and image-guided surgery. It also offers web-based therapy management software solutions. The other major players in the market include Aleva Neurotherapeutics SA, Cogentix Medical Inc, Depuy Synthes Companies, Dr. Langer Medical GMBH, EBS Technologies Gmbh, Intrapace Inc, Neurological Surgery PC, Neuronetics Inc, Nevro Corp, and the Magstim Company Limited.

TABLE OF CONTENTS

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. NEUROSTIMULATION DEVICE MARKET IS GROWING AT A MODERATE RATE
    • 3.2.2. UNITED STATES IS THE MAJOR REVENUE CONTRIBUTOR
    • 3.2.3. AID IN THE THERAPEUTIC ACTIVATE

4. MARKET DETERMINANTS

  • 4.1. MARKET DRIVERS
    • 4.1.1. HIGH OCCURRENCE OF DISEASES
    • 4.1.2. DEVELOPMENTS IN TECHNOLOGY
    • 4.1.3. INCREASED POPULACE OF ELDERLY PEOPLE
    • 4.1.4. SECOND-LINE OF TREATMENT
  • 4.2. RESTRAINTS
    • 4.2.1. HIGH VALUE OF SCS DEVICE AND EARLY TREATMENT
    • 4.2.2. POSSIBLE SIDE EFFECTS OF SCS THERAPY AND COMPLICATIONS
    • 4.2.3. ANONYMOUS APPLIANCE OF SCS THERAPY
  • 4.3. OPPORTUNITIES
    • 4.3.1. DEVELOPMENT OF INDICATION FOR SCS
    • 4.3.2. REQUIREMENT FOR MRI DEVICES
    • 4.3.3. GROWING OCCURRENCE OF CHRONIC DISCOMFORT
  • 4.4. MARKET CHALLENGES
    • 4.4.1. OBTAINABILITY OF ALTERNATIVE THERAPY
    • 4.4.2. HIGH PRICE OF TREATMENT
    • 4.4.3. SAFETY CONCERNS

5. MARKET SEGMENTATION

  • 5.1. MARKET BY SYSTEM 2017-2025
    • 5.1.1. GLOBAL SCS SYSTEM MARKET
    • 5.1.2. GLOBAL DBS SYSTEM MARKET
    • 5.1.3. GLOBAL SNS SYSTEM MARKET
    • 5.1.4. GLOBAL VNS SYSTEM MARKET
    • 5.1.5. OTHERS
  • 5.2. MARKET BY APPLICATION 2017-2025
    • 5.2.1. PAIN MANAGEMENT MARKET
    • 5.2.2. EPILEPSY MARKET
    • 5.2.3. ESSENTIAL TREMOR MARKET
    • 5.2.4. URINARY AND FECAL INCONTINENCE MARKET
    • 5.2.5. DEPRESSION MARKET
    • 5.2.6. DYSTONIA MARKET
    • 5.2.7. GASTROPARESIS MARKET
    • 5.2.8. PARKINSON'S DISEASE MARKET

6. KEY ANALYTICS

  • 6.1. PORTERS 5 FORCES ANALYSIS
    • 6.1.1. THREAT OF NEW ENTRANTS
    • 6.1.2. THREAT OF SUBSTITUTES
    • 6.1.3. BARGAINING POWER OF SUPPLIERS
    • 6.1.4. BARGAINING POWER OF BUYERS
    • 6.1.5. THREAT OF RIVALRY
  • 6.2. ESTIMATION ANALYSIS
    • 6.2.1. INCREASING PREVALENCE OF MENTAL HEALTH PROBLEME
    • 6.2.2. RISING HEALTHCARE EXPENDITURE ACROSS THE GLOBE
    • 6.2.3. RISING GERIATRIC POPULATION
  • 6.3. VALUE CHAIN ANALYSIS
    • 6.3.1. FOR DRUGS
      • 6.3.1.1. MANUFACTURERS
      • 6.3.1.2. DISTRIBUTORS
      • 6.3.1.3. RETAILERS
      • 6.3.1.4. END-USERS
    • 6.3.2. FOR DEVICES
      • 6.3.2.1. MANUFACTURERS
      • 6.3.2.2. DISTRIBUTORS
      • 6.3.2.3. END-USERS
  • 6.4. OPPORTUNITY MATRIX
  • 6.5. VENDOR LANDSCAPE

7. GEOGRAPHICAL ANALYSIS

  • 7.1. NORTH AMERICA
    • 7.1.1. UNITED STATES
    • 7.1.2. CANADA
  • 7.2. EUROPE
    • 7.2.1. UNITED KINGDOM
    • 7.2.2. FRANCE
    • 7.2.3. GERMANY
    • 7.2.4. SPAIN
    • 7.2.5. REST OF EUROP
  • 7.3. ASIA-PACIFIC
    • 7.3.1. INDIA
    • 7.3.2. CHINA
    • 7.3.3. JAPAN
    • 7.3.4. AUSTRALIA
    • 7.3.5. REST OF APAC
  • 7.4. REST OF WORLD

8. COMPANY PROFILES

  • 8.1. ALEVA NEUROTHERAPEUTICS SA
  • 8.2. BOSTON SCIENTIFIC CORPORATION
  • 8.3. COGENTIX MEDICAL INC
  • 8.4. CYBERONICS INC
  • 8.5. DEPUY SYNTHES COMPANIES
  • 8.6. DR. LANGER MEDICAL GMBH
  • 8.7. EBS TECHNOLOGIES GMBH
  • 8.8. INTRAPACE INC
  • 8.9. MEDTRONIC PLC
  • 8.10. NEUROLOGICAL SURGERY PC
  • 8.11. NEURONETICS INC
  • 8.12. NEVRO CORP.
  • 8.13. ST. JUDE MEDICAL, INC.
  • 8.14. THE MAGSTIM COMPANY LIMITED

TABLE LIST

  • TABLE # 1 GLOBAL NEUROSTIMULATION MARKET BY REGION 2017-2025($ MILLION)
  • TABLE # 2 GLOBAL SYSTEM MARKET 2017-2025 ($ MILLIONS)
  • TABLE # 3 GLOBAL NEUROSTIMULATION MARKET, BY APPLICATION 2017-2025 ($ MILLIONS)
  • TABLE # 4 GLOBAL NEUTRACEUTICAL DEVICE MARKET, BY REGION 2017-2025 ($ MILLION)
  • TABLE # 5 CONDITION TREATED BY NEUROSTIMULATION DEVICES IN US
  • TABLE # 6 NORTH AMERICA NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • TABLE # 7 EUROPE NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • TABLE # 8 ASIA PACIFIC NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)

FIGURE LIST

  • FIGURE # 1 GLOBAL NEUROSTIMULATION MARKET 2017-2025($ MILLION)
  • FIGURE # 2 GLOBAL SCS SYSTEM MARKET 2017-2025 ($ MILLIONS)
  • FIGURE # 3 GLOBAL DBS SYSTEM MARKET 2017-2025 ($ MILLIONS)
  • FIGURE # 4 GLOBAL SNS SYSTEM MARKET 2017-2025 ($ MILLIONS)
  • FIGURE # 5 GLOBAL VNS SYSTEM MARKET 2017-2025 ($ MILLIONS)
  • FIGURE # 6 GLOBAL OTHER SYSTEM MARKET 2017-2025 ($ MILLIONS)
  • FIGURE # 7 GLOBAL PAIN MANAGEMENT MARKET 2017-2025 ($ MILLIONS)
  • FIGURE # 8 GLOBAL EPILEPSY MARKET 2017-2025 ($ MILLIONS)
  • FIGURE # 9 GLOBAL ESSENTIAL TREMOR MARKET 2017-2025 ($ MILLIONS)
  • FIGURE # 10 GLOBAL URINARY AND FECAL INCONTINENCE MARKET 2017-2025 ($ MILLIONS)
  • FIGURE # 11 GLOBAL DEPRESSION MARKET 2017-2025 ($ MILLIONS)
  • FIGURE # 12 GLOBAL DYSTONIA MARKET 2017-2025 ($ MILLIONS)
  • FIGURE # 13 GLOBAL GASTROPARESIS MARKET 2017-2025 ($ MILLIONS)
  • FIGURE # 14 GLOBAL PARKINSON'S DISEASE MARKET 2017-2025 ($ MILLIONS)
  • FIGURE # 15 PREVALENCE OF MENTAL HEALTH DISORDERS ACROSS THE GLOBE BETWEEN PERIOD 2012 AND 2020 (MILLION)
  • FIGURE # 16 RISING GERIATRIC POPULATION ACROSS THE GLOBE FOR PERIOD 2014-2020 (MILLION)
  • FIGURE # 17 VALUE CHAIN OF ANTIDEPRESSANT DRUGS
  • FIGURE # 18 UNITED STATES NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • FIGURE # 19 CANADA NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • FIGURE # 20 UNITED KINGDOM NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • FIGURE # 21 FRANCE NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • FIGURE # 22 GERMANY NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • FIGURE # 23 SPAIN NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • FIGURE # 24 REST OF EUROPE NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • FIGURE # 25 INDIA NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • FIGURE # 26 CHINA NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • FIGURE # 27 JAPAN NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • FIGURE # 28 AUSTRALIA NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • FIGURE # 29 REST OF APAC NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • FIGURE # 30 REST OFWORLD NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
Back to Top